Recombinant human LTA/TNF-beta protein

Cat No.
ATGP3420

Size

QTY

List Price

10ug

USD 130


20ug

USD 240

50ug

USD 320

100ug

USD 530

250ug

USD 930

500ug

USD 1,590

USD 0



Product Information

Product Type
Recombinant Protein
Expression System
Baculovirus
Domain
35-205aa
UniProt No.
P01374
NCBI Accession No.
NP_001153212
Alternative names
Lymphotoxin-alpha, LT-alpha, TNF-beta, Tumor necrosis factor ligand superfamily member 1, TNFB, TNFSF1, TNF superfamily, member 1

Product Specification

Molecular Weight
19.7 kDa (180aa)
Concentration
0.5mg/ml (determined by absorbance at 280nm)
Formulation
Liquid in. Phosphate-Buffered Saline (pH 7.4) containing 10% glycerol
Purity
> 90% by SDS-PAGE
Bioactivity
Measured in a cytotoxicity assay using L-929 mouse fibroblast cells in the presence of the metabolic inhibitor actinomycin D. The ED50 range ≤ 1ng/ml.
Endotoxin
< 1 EU per 1ug of protein (determined by LAL method)
Tag
His-Tag
Applications
SDS-PAGE, Bioactivity
Storage
Can be stored at +2C to +8C for 1 week. For long term storage, aliquot and store at -20C to -80C. Avoid repeated freezing and thawing cycles.

Data

SDS-PAGE

3ug by SDS-PAGE under reducing condition and visualized by coomassie blue stain.

Biological Activity

Human LTA/TNF-beta induces cell cytotoxicity in the L-929 mouse fibroblast cells in the presence of the metabolic inhibitor actinomycin D.

Note: For research use only. This product is not intended or approved for human, diagnostics or veterinary use.